ENTITY

Eco Animal Health Group (EAH LN)

20
Analysis
Health Care • United Kingdom
Eco Animal Health Group develops, registers, and markets pharmaceutical products for animals globally, specializing in veterinary pharmaceuticals, antibiotics, and vaccines for pigs and poultry. Its key product, Aivlosin®, is a macrolide antibiotic used to treat respiratory and enteric diseases in pigs and poultry. The company also offers generic drugs for parasitic and bacterial infections in various livestock. Headquartered in London, England, the company was founded in 1972.
more
•27 Feb 2026 16:00•Issuer-paid

Eco Animal Health - ECOVAXXIN® MS commercialisation begins

Following the announcement in December 2025 of European Commission marketing authorisation, Eco Animal Health has announced its commercialisation...

Logo
183 Views
Share
•22 Dec 2025 16:00•Issuer-paid

Early EU authorisation for ECOVAXXIN® MS

ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for...

Logo
216 Views
Share
•01 Dec 2025 16:00•Issuer-paid

Eco Animal Health - HY26: momentum accelerates

Eco Animal Health delivers a strong H1 FY26 performance. Revenue surged 19% YoY to ÂŁ39.4m, ahead of guidance, with adjusted EBITDA up to ÂŁ3.0m...

Logo
283 Views
Share
•10 Nov 2025 23:00•Issuer-paid

Eco Animal Health - ECOVAXXIN® MS EU authorisation paves way for commercial launch

Eco Animal Health reports that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has adopted a...

Logo
177 Views
Share
•10 Jan 2025 22:18•Issuer-paid

Hardman & Co Healthcare Index: 2024 – Tough year for Life Sciences

The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments...

Logo
514 Views
Share
x